Phase II Umbrella Study Directed by Next Generation Sequencing

NCT03574402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Avitinib Maleate
DRUG: Afatinib
DRUG: Crizotinib
DRUG: X-396
DRUG: Chidamide
DRUG: Pyrotinib Maleate
DRUG: AZD3759
DRUG: Pirotinib
DRUG: Nimotuzumab
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Sintilimab
DRUG: Gemcitabine
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

Guangdong Association of Clinical Trials

Collaborators

[object Object]